cAMP-dependent protein kinase inhibitor alpha

BE0003762ProteinHumansPKIA

Extremely potent competitive inhibitor of cAMP-dependent protein kinase activity, this protein interacts with the catalytic subunit of the enzyme after the cAMP-induced dissociation of its regulatory chains. It is acted on by 30 drugs in DrugBank.

Gene name
PKIA
UniProtKB entry
P61925Swiss-Prot
Residues / weight
76 residues · 7,988 Da
Also known as
cAMP-dependent protein kinase inhibitor, muscle/brain isoform · PKI-alpha · PRKACN1

Resolves to

Pharmacology

What you can answer from here — as of September 07, 2019

30DrugsApproved to experimental, with action, bond type and pharmacological action
Sign in
5GO termsFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
33+ReferencesStructured and connected to the statements they support
Sign in

Which compounds in development act on cAMP-dependent protein kinase inhibitor alpha, and which indications are they being tested in?

Create a free account or log in to explore the full data card.

Create Account